651 - 675 of 8620 Results
Title
Year
- Transcriptomic analysis to identify genes associated with selective hippocampal vulnerability in Alzheimer’s disease2021OPENTitle: Transcriptomic analysis to identify genes associated with selective hippocampal vulnerability in Alzheimer’s diseaseJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-021-22399-3Best OA location URL: https://www.nature.com/articles/s41467-021-22399-3.pdfCitation Count: 69
- Unified AI framework to uncover deep interrelationships between gene expression and Alzheimer’s disease neuropathologies2021OPENTitle: Unified AI framework to uncover deep interrelationships between gene expression and Alzheimer’s disease neuropathologiesJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-021-25680-7Best OA location URL: https://www.nature.com/articles/s41467-021-25680-7.pdfCitation Count: 15
- Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson’s disease2021OPENTitle: Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson’s diseaseJournal Name: Nature GeneticsPublisher: Springer Science and Business Media LLCVol: 53Issue #: 6Start Page: 787End Page: 793Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41588-021-00847-6Best OA location URL: http://hdl.handle.net/1887/3249471Citation Count: 116
- Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture2021OPENTitle: Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architectureJournal Name: Nature GeneticsPublisher: Springer Science and Business Media LLCVol: 53Issue #: 3Start Page: 294End Page: 303Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41588-021-00785-3Best OA location URL: https://escholarship.org/uc/item/7qn6v913Citation Count: 314
- Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial2021RESTRICTEDTitle: Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trialJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 27Issue #: 8Start Page: 1451End Page: 1457Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41591-021-01455-xCitation Count: 103
- Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer’s disease pathogenesis2021OPENTitle: Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer’s disease pathogenesisJournal Name: Nature GeneticsPublisher: Springer Science and Business Media LLCVol: 53Issue #: 2Start Page: 143End Page: 146Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41588-020-00773-zBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8130821Citation Count: 292
-
RESTRICTEDTitle: Aducanumab: look before leapingJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 27Issue #: 9Start Page: 1499End Page: 1499Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41591-021-01477-5Citation Count: 11
-
OPENTitle: Brain proteome-wide association study implicates novel proteins in depression pathogenesisJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 24Issue #: 6Start Page: 810End Page: 817Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41593-021-00832-6Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8530461Citation Count: 139
-
OPENTitle: Effects of Levodopa on quality of sleep and nocturnal movements in Parkinson’s DiseaseJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 268Issue #: 7Start Page: 2506End Page: 2514Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-021-10419-7Best OA location URL: https://pub.dzne.de/search?p=id:%22DZNE-2021-00821%22Citation Count: 21
-
OPENTitle: Trajectories of pain over 6 years in early Parkinson’s disease: ICICLE-PDJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 268Issue #: 12Start Page: 4759End Page: 4767Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-021-10586-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-021-10586-7.pdfCitation Count: 10
- Memory enhancement by multidomain group cognitive training in patients with Parkinson’s disease and mild cognitive impairment: long-term effects of a multicenter randomized controlled trial2021OPENTitle: Memory enhancement by multidomain group cognitive training in patients with Parkinson’s disease and mild cognitive impairment: long-term effects of a multicenter randomized controlled trialJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 268Issue #: 12Start Page: 4655End Page: 4666Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-021-10568-9Best OA location URL: https://pub.dzne.de/record/155574Citation Count: 18
- Disentangling the PIGD classification for the prediction of cognitive impairment in de novo Parkinson’s disease2021OPENTitle: Disentangling the PIGD classification for the prediction of cognitive impairment in de novo Parkinson’s diseaseJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 269Issue #: 3Start Page: 1566End Page: 1573Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-021-10730-3Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-021-10730-3.pdfCitation Count: 10
-
OPENTitle: Energy expenditure, body composition and dietary habits in progressive supranuclear palsyJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 269Issue #: 5Start Page: 2610End Page: 2618Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00415-021-10846-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-021-10846-6.pdfCitation Count: 3
-
RESTRICTEDTitle: Acetyl-dl-leucine improves restless legs syndrome: a case reportJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 268Issue #: 7Start Page: 2595End Page: 2596Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00415-021-10625-3Citation Count: 7
- APOE genotype dependent molecular abnormalities in the cerebrovasculature of Alzheimer’s disease and age-matched non-demented brains2021OPENTitle: APOE genotype dependent molecular abnormalities in the cerebrovasculature of Alzheimer’s disease and age-matched non-demented brainsJournal Name: Molecular BrainPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13041-021-00803-9Best OA location URL: https://molecularbrain.biomedcentral.com/counter/pdf/10.1186/s13041-021-00803-9Citation Count: 24
- Dual monoamine oxidase B and acetylcholine esterase inhibitors for treating movement and cognition deficits in a C. elegans model of Parkinson’s disease2021OPENTitle: Dual monoamine oxidase B and acetylcholine esterase inhibitors for treating movement and cognition deficits in a C. elegans model of Parkinson’s diseaseJournal Name: Medicinal Chemistry ResearchPublisher: Springer Science and Business Media LLCVol: 30Issue #: 5Start Page: 1166End Page: 1174Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00044-021-02720-xBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8570587Citation Count: 3
- Decrease in Skin Prion-Seeding Activity of Prion-Infected Mice Treated with a Compound Against Human and Animal Prions: a First Possible Biomarker for Prion Therapeutics2021OPENTitle: Decrease in Skin Prion-Seeding Activity of Prion-Infected Mice Treated with a Compound Against Human and Animal Prions: a First Possible Biomarker for Prion TherapeuticsJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 58Issue #: 9Start Page: 4280End Page: 4292Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s12035-021-02418-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s12035-021-02418-6.pdfCitation Count: 15
- Endosomal traffic and glutamate synapse activity are increased in VPS35 D620N mutant knock-in mouse neurons, and resistant to LRRK2 kinase inhibition2021OPENTitle: Endosomal traffic and glutamate synapse activity are increased in VPS35 D620N mutant knock-in mouse neurons, and resistant to LRRK2 kinase inhibitionJournal Name: Molecular BrainPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13041-021-00848-wBest OA location URL: https://molecularbrain.biomedcentral.com/track/pdf/10.1186/s13041-021-00848-wCitation Count: 17
- Metabolic Profile in Plasma AND CSF of LEVODOPA-induced Dyskinesia in Parkinson’s Disease: Focus on Neuroinflammation2021OPENTitle: Metabolic Profile in Plasma AND CSF of LEVODOPA-induced Dyskinesia in Parkinson’s Disease: Focus on NeuroinflammationJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 59Issue #: 2Start Page: 1140End Page: 1150Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s12035-021-02625-1Citation Count: 15
-
OPENTitle: SETD7-mediated monomethylation is enriched on soluble Tau in Alzheimer’s diseaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 16Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-021-00468-xBest OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s13024-021-00468-xCitation Count: 19
- Role of Neuroinflammation in the Establishment of the Neurogenic Microenvironment in Brain Diseases2021OPENTitle: Role of Neuroinflammation in the Establishment of the Neurogenic Microenvironment in Brain DiseasesJournal Name: Current Tissue Microenvironment ReportsPublisher: Springer Science and Business Media LLCVol: 2Issue #: 2Start Page: 17End Page: 28Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s43152-021-00028-xCitation Count: 2
-
RESTRICTEDTitle: Contextual in situ help for visual data interfacesJournal Name: Information VisualizationPublisher: SAGE PublicationsVol: 22Issue #: 1Start Page: 69End Page: 84Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1177/14738716221120064Citation Count: 7
- Quantification of the purinergic P2X7 receptor with [11C]SMW139 improves through correction for brain-penetrating radiometabolites2022OPENTitle: Quantification of the purinergic P2X7 receptor with [11C]SMW139 improves through correction for brain-penetrating radiometabolitesJournal Name: Journal of Cerebral Blood Flow & MetabolismPublisher: SAGE PublicationsVol: 43Issue #: 2Start Page: 258End Page: 268Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1177/0271678x221126830Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/0271678X221126830Citation Count: 5
-
OPENTitle: Association between cigarette smoking and Parkinson’s disease: a neuroimaging studyJournal Name: Therapeutic Advances in Neurological DisordersPublisher: SAGE PublicationsVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/17562864221092566Best OA location URL: https://doi.org/10.1177/17562864221092566Citation Count: 26
- Inhibitory synaptic loss drives network changes in multiple sclerosis: An ex vivo to in silico translational study2022OPENTitle: Inhibitory synaptic loss drives network changes in multiple sclerosis: An ex vivo to in silico translational studyJournal Name: Multiple Sclerosis JournalPublisher: SAGE PublicationsVol: 28Issue #: 13Start Page: 2010End Page: 2019Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1177/13524585221125381Best OA location URL: https://doi.org/10.1177/13524585221125381Citation Count: 22